One pearl of wisdom per day
A patient is being assessed for transplant. He has a panel-reactive antibody (PRA) of 30% by the complement-dependent cytotoxicity (CDC) technique but 0% for Class I and II antigens by flow cytometry (Luminex).
How can you explain the difference between these tests?
Subscribe today! It’s always free, and you can easily unsubscribe at any time. We will never share your email address. Subscribe to...
• Multiple Pearls
• Cardiology Pearls
• Endocrinology Pearls
• Hematology Pearls
• Nephrology Pearls
• Rheumatology Pearls
• Transplant Pearls
• General Internal Medicine Pearls
• Instructor Pearls
Subscribe to receive your pearls today—it's free!